Showing 1,701 - 1,720 results of 5,371 for search '"Virus"', query time: 0.09s Refine Results
  1. 1701
  2. 1702
  3. 1703
  4. 1704
  5. 1705

    Nucleic Acid Aptamers for Human Norovirus GII.4 and GII.17 Virus-Like Particles (VLPs) Exhibit Specific Binding and Inhibit VLPs from Entering Cells by Cheng C, Sun M, Li J, Xue Y, Cai X, Liu J, Wang X, Xu S, Xie Y, Zhang J

    Published 2025-02-01
    “…Here, we screened nucleic acid aptamers against the widespread HuNoV GII.4 and emerging HuNoV GII.17.Methods: After ten rounds of sieving for HuNoV GII.4 and GII.17 virus-like particles (VLPs), eight ssDNA aptamers were generated and characterized for each genotype.Results: Four of the eight aptamers generated for GII.4 VLP had dissociation constants (Kd) less than 100 nM, and all aptamers for GII.17 VLP had Kd less than 10 nM. …”
    Get full text
    Article
  6. 1706
  7. 1707
  8. 1708
  9. 1709

    Peptide-Based Vaccinology: Experimental and Computational Approaches to Target Hypervariable Viruses through the Fine Characterization of Protective Epitopes Recognized by Monoclonal Antibodies and the Identification of T-Cell-Activating Peptides by Matteo Castelli, Francesca Cappelletti, Roberta Antonia Diotti, Giuseppe Sautto, Elena Criscuolo, Matteo Dal Peraro, Nicola Clementi

    Published 2013-01-01
    “…This is particularly important for the selective targeting of conserved regions shared among hypervariable viruses. Studying postinfection and postimmunization sera, as well as cloning and characterization of monoclonal antibodies (mAbs), still represents the best approach to identify protective epitopes. …”
    Get full text
    Article
  10. 1710

    Contemporary Antiviral Drug Regimens for the Prevention and Treatment of Orolabial and Anogenital Herpes Simplex Virus Infection in the Normal Host: Four Approved Indications and 13 Off-Label Uses by Fred Y Aoki

    Published 2003-01-01
    “…Herpes simplex virus (HSV) orolabial and anogenital infection causes substantial and recurring disease in healthy individuals due directly to infection of these sites and, indirectly, due to its complications. …”
    Get full text
    Article
  11. 1711
  12. 1712

    Activation of MEK1/2/Nrf-2 Signaling Pathway by Epstein-Barr Virus-Latent Membrane Protein 1 Enhances Autophagy and Cisplatin Resistance in T-Cell Lymphoma by Xintao Jia, Qiuyu He, Mei Zeng, Yuhua Chen, Yan Liu

    Published 2021-01-01
    “…Epstein-Barr virus-latent membrane protein 1 (EBV-LMP1) was associated with lymphoma, but its specific mechanism is still controversial. …”
    Get full text
    Article
  13. 1713

    A lineage 1 branch porcine reproductive and respiratory syndrome virus live vaccine candidate provides broad cross-protection against HP-like PRRSV in piglets by Chao Li, Jinhao Li, Bangjun Gong, Hu Xu, Zhenyang Guo, Lirun Xiang, Siyu Zhang, Qi Sun, Jing Zhao, Menglin Zhang, Yan-Dong Tang, Chaoliang Leng, Jianan Wu, Qian Wang, Jinmei Peng, Guohui Zhou, Huairan Liu, Tongqing An, Xuehui Cai, Zhi-Jun Tian, Hongliang Zhang

    Published 2025-12-01
    “…Multiple porcine reproductive and respiratory syndrome virus (PRRSV) subtypes coinfect numerous pig farms in China, and commercial PRRSV vaccines offer limited cross-protection against heterologous strains. …”
    Get full text
    Article
  14. 1714
  15. 1715
  16. 1716
  17. 1717
  18. 1718
  19. 1719

    Caracterización sociodemográfica y conductual de hombres con infección por el virus de inmunodeficiencia humana. Área de salud I.... by Katiuska Díaz Quintero, María Lina Valdés Gómez, Leticia Castro Morejón, Julio César Díaz Marrero, José Aurelio Díaz Quiñones, Esther Yarinely Hernández Dieguez

    Published 2018-04-01
    “…<strong>Fundamento:</strong> la principal batalla contra el virus de inmunodeficiencia humana/sida es la prevención, para ello es necesario tener en cuenta los grupos más vulnerables y los factores de riesgo asociados.…”
    Get full text
    Article
  20. 1720